Drug Trial Radar · NCT01965652
Long Term Safety of Naldemedine
Last checked: Nov 20, 2026Latest source record: Apr 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,246
Actual
Start
Sep 24, 2013
Primary completion
Jan 12, 2016
Study completion Jan 12, 2016
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Oct 18, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety of naldemedine for the treatment of constipation due to opioid therapy.
Conditions
- Opioid-induced Constipation
Interventions
NaldemedineDrug
Naldemedine 0.2 mg tablet taken orally once a day
PlaceboDrug
Placebo tablet taken orally once a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse EventsTime frame: From the first dose of study drug up to 14 days after the last dose of study drug (54 weeks).
Locations
186 sites in 16 countries. Site status is shown where the registry gives one.
Shionogi Research Site
Birmingham, Alabama
Shionogi Research Site
Mobile, Alabama
Shionogi Research Site
Chandler, Arizona
Shionogi Research Site
Glendale, Arizona
Shionogi Research Site
Goodyear, Arizona
Shionogi Research Site
Mesa, Arizona
Shionogi Research Site
Phoenix, Arizona
Shionogi Research Site
Tucson, Arizona
Shionogi Research Site
Fountain Valley, California
Shionogi Research Site
Garden Grove, California
Shionogi Research Site
Glendale, California
Shionogi Research Site
Long Beach, California
Shionogi Research Site
Los Angeles, California
Shionogi Research Site
Oceanside, California
Shionogi Research Site
Sacramento, California
Shionogi Research Site
Santa Ana, California
Shionogi Research Site
Upland, California
Shionogi Research Site
Colorado Springs, Colorado
Shionogi Research Site
Boynton Beach, Florida
Shionogi Research Site
Brandon, Florida
Shionogi Research Site
Brooksville, Florida
Shionogi Research Site
Clearwater, Florida
Shionogi Research Site
Fort Myers, Florida
Shionogi Research Site
Jacksonville, Florida
Shionogi Research Site
Lake City, Florida
Shionogi Research Site
Lakeland, Florida
Shionogi Research Site
Orlando, Florida
Shionogi Research Site
South Miami, Florida
Shionogi Research Site
St. Petersburg, Florida
Shionogi Research Site
Tampa, Florida
Shionogi Research Site
Atlanta, Georgia
Shionogi Research Site
Blue Ridge, Georgia
Shionogi Research Site
Decatur, Georgia
Shionogi Research Site
Savannah, Georgia
Shionogi Research Site
Boise, Idaho
Shionogi Research Site
Aurora, Illinois
Shionogi Research Site
Bloomington, Illinois
Shionogi Research Site
Decatur, Illinois
Shionogi Research Site
Rockford, Illinois
Shionogi Research Site
Schaumburg, Illinois
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.